Inflammatory response in islet transplantation

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Kanak, Mazhar A ^a   Takita, Morihito ^b   Kunnathodi, Faisal ^b   Lawrence, Michael C ^b   Levy, Marlon F ^c   Naziruddin, Bashoo ^c  

^a BAYLOR UNIVERSITY   (United States)

^b BAYLOR RESEARCH INSTITUTE   (United States)

^c Annette C and Harold C Simmons Transplant Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIINFLAMMATORY AGENT; CYCLOSPORIN; CYTOKINE; DACLIZUMAB; DEXTRAN; ETANERCEPT; EVEROLIMUS; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INFLIXIMAB; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; RAPAMYCIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIMVASTATIN; STEROID; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TACROLIMUS; THROMBOPLASTIN; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; BLOOD CLOTTING; BRAIN DEATH; CELL CULTURE; CELL DAMAGE; CELL INFILTRATION; CELL ISOLATION; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; INSTANT BLOOD MEDIATED MEDIATED INFLAMMATORY REACTION; LEUKOCYTE; NONHUMAN; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION;

EID: 84901020343     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/451035     Document Type: Article

References (149)

1. Kemp C. B., Knight M. J., Scharp D. W., Ballinger W. F., Lacy P. E., Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973 9 6 486 491 2-s2.0-0015754819
2. Hering B. J., Insulin independence following islet transplantation in man: a comparison of different recipient categories. International Islet Transplant Registry 1996 6 5 19
3. Shapiro A. M. J., Lakey J. R. T., Ryan E. A., Korbutt G. S., Toth E., Warnock G. L., Kneteman N. M., Rajotte R. V., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New England Journal of Medicine 2000 343 4 230 238 2-s2.0-0034721255 10.1056/NEJM200007273430401 (Pubitemid 30490390)
4. Braganza J. M., Lee S. H., McCloy R. F., McMahon M. J., Chronic pancreatitis. The Lancet 2011 377 9772 1184 1197 2-s2.0-79953293021 10.1016/S0140-6736(10)61852-1
5. Nair R. J., Lawler L., Miller M. R., Chronic pancreatitis. American Family Physician 2007 76 11 1679 1688 2-s2.0-36849078746
6. Behrman S. W., Fowler E. S., Pathophysiology of chronic pancreatitis. Surgical Clinics of North America 2007 87 6 1309 1324 2-s2.0-36349019762 10.1016/j.suc.2007.09.001 (Pubitemid 350160792)
7. Sutherland D. E. R., Matas A. J., Najarian J. S., Pancreatic islet cell transplantation. Surgical Clinics of North America 1978 58 2 365 382 2-s2.0-0018171379 (Pubitemid 9045380)
8. Seventh Annual Report of the Collaborative Islet Transplant Registry. 2011, http://www.citregistry.org/
9. Sutherland D. E. R., Gruessner A. C., Carlson A. M., Blondet J. J., Balamurugan A. N., Reigstad K. F., Beilman G. J., Bellin M. D., Hering B. J., Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 2008 86 12 1799 1802 2-s2.0-58849158813 10.1097/TP.0b013e31819143ec
10. Birks E. J., Owen V. J., Burton P. B. J., Bishop A. E., Banner N. R., Khaghani A., Polak J. M., Yacoub M. H., Tumor necrosis factor- α is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000 102 3 326 331 2-s2.0-0034682603 (Pubitemid 30457584)
11. Nijboer W. N., Schuurs T. A., van der Hoeven J. A. B., Fekken S., Wiersema-Buist J., Leuvenink H. G. D., Hofker S., van der Heide J. J. H., van Son W. J., Ploeg R. J., Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004 78 7 978 986 2-s2.0-6344229194 10.1097/01.TP.0000135565.49535.60 (Pubitemid 39391858)
12. Fisher A. J., Donnelly S. C., Hirani N., Haslett C., Strieter R. M., Dark J. H., Corris P. A., Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. American Journal of Respiratory and Critical Care Medicine 2001 163 1 259 265 2-s2.0-0035154685 (Pubitemid 32095278)
13. Murugan R., Venkataraman R., Wahed A. S., Elder M., Hergenroeder G., Carter M., Madden N. J., Powner D., Kellum J. A., Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Critical Care Medicine 2008 36 6 1810 1816 2-s2.0-45149134354 10.1097/CCM.0b013e318174d89f
14. Chhabra P., Brayman K. L., Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. Journal of Transplantation 2011 2011 24 637692 10.1155/2011/637692
15. Kutlu B., Cardozo A. K., Darville M. I., Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 Cells. Diabetes 2003 52 11 2701 2719 2-s2.0-0242363618 10.2337/diabetes.52.11. 2701 (Pubitemid 37339700)
16. Barklin A., Larsson A., Vestergaard C., Insulin alters cytokine content in two pivotal organs after brain death: a porcine model. Acta Anaesthesiologica Scandinavica 2008 52 5 628 634 2-s2.0-42249104700 10.1111/j.1399-6576.2008. 01606.x (Pubitemid 351549566)
17. Shinichiro O., Kuroki T., Adachi T., Kosaka T., Okamoto T., Tanaka T., Tajima Y., Kanematsu T., Eguchi S., The effect of selective neutrophil elastase inhibitor on pancreatic islet yields and functions in rat with hypercytokinemia. Annals of Transplantation 2011 16 4 99 106 2-s2.0-84855492221
18. Kühtreiberc W. M., Ho L. T., Kamireddy A., Yacoub J. A. W., Scharp D. W., Islet isolation from human pancreas with extended cold ischemia time. Transplantation Proceedings 2010 42 6 2027 2031 2-s2.0-77955537416 10.1016/j.transproceed.2010.05.099
19. Tsujimura T., Kuroda Y., Churchill T. A., Avila J. G., Kin T., Shapiro A. M. J., Lakey J. R. T., Short-term storage of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Cell Transplantation 2004 13 1 67 73 2-s2.0-1342288556 (Pubitemid 38252715)
20. de Vos P., van Straaten J. F. M., Nieuwenhuizen A. G., de Groot M., Ploeg R. J., de Haan B. J., van Schilfgaarde R., Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 1999 48 7 1381 1388 2-s2.0-0032990929 10.2337/diabetes.48.7.1381 (Pubitemid 29297299)
21. de Groot M., Schuurs T. A., Keizer P. P. M., Fekken S., Leuvenink H. G. D., van Schilfgaarde R., Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplantation 2003 12 8 867 875 2-s2.0-0347086156
22. Semenza G. L., Life with oxygen. Science 2007 318 5847 62 64 2-s2.0-35148888161 10.1126/science.1147949 (Pubitemid 47538005)
23. Naugler W. E., Karin M., NF- κ B and cancer-identifying targets and mechanisms. Current Opinion in Genetics & Development 2008 18 1 19 26 10.1016/j.gde.2008.01.020 (Pubitemid 351694451)
24. Vallabhapurapu S., Karin M., Regulation and function of NF- κ B transcription factors in the immune system. Annual Review of Immunology 2009 27 693 733 2-s2.0-67650724069 10.1146/annurev.immunol.021908.132641
25. Pasparakis M., IKK/NF- κ B signaling in intestinal epithelial cells controls immune homeostasis in the gut. Mucosal Immunology 2008 1, supplement 1 S54 S57 2-s2.0-54349107492 10.1038/mi.2008.53
26. Taylor C. T., Interdependent roles for hypoxia inducible factor and nuclear factor- κ B in hypoxic inflammation. The Journal of Physiology 2008 586, part 17 4055 4059 2-s2.0-51749089798 10.1113/jphysiol.2008.157669
27. Cummins E. P., Berra E., Comerford K. M., Ginouves A., Fitzgerald K. T., Seeballuck F., Godson C., Nielsen J. E., Moynagh P., Pouyssegur J., Taylor C. T., Prolyl hydroxylase-1 negatively regulates I κ B kinase- β giving insight into hypoxia-induced NF κ B activity. Proceedings of the National Academy of Sciences of the United States of America 2006 103 48 18154 18159 2-s2.0-33845321931 10.1073/pnas.0602235103 (Pubitemid 44871628)
28. Negi S., Jetha A., Aikin R., Hasilo C., Sladek R., Paraskevas S., Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS ONE 2012 7 1 2-s2.0-84856394012 10.1371/journal.pone.0030415 e30415
29. Ilmakunnas M., Höckerstedt K., Mäkisalo H., Siitonen S., Repo H., Pesonen E. J., Hepatic IL-8 release during graft procurement is associated with impaired graft function after human liver transplantation. Clinical Transplantation 2010 24 1 29 35 2-s2.0-74949095868 10.1111/j.1399-0012.2009. 00975.x
30. Rao J. N., Clark S. C., Ali S., Kirby J., Flecknell P. A., Dark J. H., Improvements in lung compliance after pulmonary transplantation: correlation with interleukin 8 expression. European Journal of Cardio-Thoracic Surgery 2003 23 4 497 502 2-s2.0-0037385143 10.1016/S1010-7940(02)00842-4 (Pubitemid 36411874)
31. de Perrot M., Sekine Y., Fischer S., Waddell T. K., Mcrae K., Liu M., Wigle D. A., Keshavjee S., Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. American Journal of Respiratory and Critical Care Medicine 2002 165 2 211 215 2-s2.0-0037080909 (Pubitemid 34084460)
32. Olsson R., Carlsson P.-O., Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia 2005 48 3 469 476 2-s2.0-16844376921 10.1007/s00125-004-1650-x (Pubitemid 40487294)
33. King A., Lock J., Xu G., Bonner-Weir S., Weir G. C., Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia 2005 48 10 2074 2079 2-s2.0-26244439281 10.1007/s00125-005-1922-0 (Pubitemid 41416919)
34. Ihm S.-H., Matsumoto I., Zhang H. J., Ansite J. D., Hering B. J., Effect of short-term culture on functional and stress-related parameters in isolated human islets. Transplant International 2009 22 2 207 216 2-s2.0-58149301669 10.1111/j.1432-2277.2008.00769.x
35. Noguchi H., Naziruddin B., Jackson A., Shimoda M., Ikemoto T., Fujita Y., Chujo D., Takita M., Peng H., Sugimoto K., Itoh T., Kobayashi N., Onaca N., Levy M. F., Matsumoto S., Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplantation 2012 21 2-3 517 523 2-s2.0-84859702743 10.3727/096368911X605439
36. Noguchi H., Naziruddin B., Shimoda M., Fujita Y., Chujo D., Takita M., Peng H., Sugimoto K., Itoh T., Tamura Y., Olsen G. S., Kobayashi N., Onaca N., Levy M. F., Matsumoto S., Comparison of fresh and cultured islets from human and porcine pancreata. Transplantation Proceedings 2010 42 6 2084 2086 2-s2.0-77955534696 10.1016/j.transproceed.2010.05.098
37. Lakey J. R., Helms L. M., Kin T., Korbutt G. S., Rajotte R. V., Shapiro A. M., Warnock G. L., Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 2001 72 4 565 570 2-s2.0-0035959374 (Pubitemid 32802735)
38. Giuliani M., Moritz W., Bodmer E., Dindo D., Kugelmeier P., Lehmann R., Gassmann M., Groscurth P., Weber M., Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transplantation 2005 14 1 67 76 2-s2.0-15244349984 (Pubitemid 40387680)
39. Moberg L., Olsson A., Berne C., Felldin M., Foss A., Kallen R., Salmela K., Tibell A., Tufveson G., Nilsson B., Korsgren O., Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 2003 76 9 1285 1288 2-s2.0-10744233687 10.1097/01.TP.0000098905.86445.0F (Pubitemid 37430712)
40. Rickels M. R., Liu C., Shlansky-Goldberg R. D., Improvement in beta-cell secretory capacity after human islet transplantation according to the CIT07 Protocol. Diabetes 2013 62 8 2890 2897 10.2337/db12-1802
41. Bennet W., Sundberg B., Groth C.-G., Brendel M. D., Brandhorst D., Brandhorst H., Bretzel R. G., Elgue G., Larsson R., Nilsson B., Korsgren O., Incompatibility between human blood and isolated islets of langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999 48 10 1907 1914 2-s2.0-0032883638 10.2337/diabetes.48.10.1907 (Pubitemid 29458351)
42. Moberg L., Johansson H., Lukinius A., Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. The Lancet 2002 360 9350 2039 2045 2-s2.0-0037153731 10.1016/S0140-6736(02)12020-4 (Pubitemid 36026584)
43. Nilsson B., Ekdahl K. N., Korsgren O., Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Current Opinion in Organ Transplantation 2011 16 6 620 626 2-s2.0-81255168048 10.1097/MOT.0b013e32834c2393
44. Naziruddin B., Iwahashi S., Kanak M. A., Takita M., Itoh T., Levy M. F., Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. American Journal of Transplantation 2014 14 2 428 437 10.1111/ajt.12558
45. Eriksson O., Eich T., Sundin A., Positron emission tomography in clinical islet transplantation. American Journal of Transplantation 2009 9 12 2816 2824 2-s2.0-72449153380 10.1111/j.1600-6143.2009.02844.x
46. Rao L. V., Rapaport S. I., Bajaj S. P., Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood 1986 68 3 685 691 2-s2.0-0022456082 (Pubitemid 16008171)
47. Morrissey J. H., Tissue factor: an enzyme cofactor and a true receptor. Thrombosis and Haemostasis 2001 86 1 66 74 2-s2.0-0034917278 (Pubitemid 32663938)
48. Donovan F. M., Pike C. J., Cotman C. W., Cunningham D. D., Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. The Journal of Neuroscience 1997 17 14 5316 5326 2-s2.0-16944366731 (Pubitemid 27300299)
49. Turgeon V. L., Lloyd E. D., Wang S., Festoff B. W., Houenou L. J., Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. The Journal of Neuroscience 1998 18 17 6882 6891 2-s2.0-17344365478 (Pubitemid 28388018)
50. Özmen L., Ekdahl K. N., Elgue G., Larsson R., Korsgren O., Nilsson B., Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor Melagatran in clinical islet transplantation. Diabetes 2002 51 6 1779 1784 2-s2.0-0036263218 (Pubitemid 34564290)
51. Johansson H., Goto M., Dufrane D., Siegbahn A., Elgue E., Gianello P., Korsgren O., Nilsson B., Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. American Journal of Transplantation 2006 6 2 305 312 (Pubitemid 43382165)
52. Cabric S., Sanchez J., Lundgren T., Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007 56 8 2008 2015 2-s2.0-34547610974 10.2337/db07-0358 (Pubitemid 47195827)
53. Johansson U., Elgue G., Nilsson B., Korsgren O., Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. American Journal of Transplantation 2005 5 11 2632 2639 2-s2.0-33644626942 10.1111/j.1600-6143.2005.01076.x
54. Kim H.-I., Yu J. E., Lee S. Y., The effect of composite pig islet-human endothelial cell grafts on the instant blood-mediated inflammatory reaction. Cell Transplantation 2009 18 1 31 37 2-s2.0-66849115467 10.3727/ 096368909788237113
55. Johansson U., Rasmusson I., Niclou S. P., Forslund N., Gustavsson L., Nilsson B., Korsgren O., Magnusson P. U., Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 2008 57 9 2393 2401 2-s2.0-52749089852 10.2337/db07-0981
56. Dwyer K. M., Mysore T. B., Crikis S., The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 2006 82 3 428 432 2-s2.0-33747115379 10.1097/01.tp.0000229023.38873.c0 (Pubitemid 44223045)
57. Tjernberg J., Ekdahl K. N., Lambris J. D., Korsgren O., Nilsson B., Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation 2008 85 8 1193 1199 2-s2.0-42549092068 10.1097/TP. 0b013e31816b22f3 (Pubitemid 351590198)
58. Fujita E., Farkas I., Campbell W., Baranyi L., Okada H., Okada N., Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a. The Journal of Immunology 2004 172 10 6382 6387 2-s2.0-2442487762 (Pubitemid 38621247)
59. Ritis K., Doumas M., Mastellos D., Micheli A., Giaglis S., Magotti P., Rafail S., Kartalis G., Sideras P., Lambris J. D., A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. The Journal of Immunology 2006 177 7 4794 4802 2-s2.0-33749118495 (Pubitemid 44469814)
60. Tokodai K., Goto M., Inagaki A., Nakanishi W., Okada N., Okada H., Satomi S., C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation. Transplantation Proceedings 2010 42 6 2102 2103 2-s2.0-77955533583 10.1016/j.transproceed.2010.05.100
61. Tokodai K., Goto M., Inagaki A., Nakanishi W., Ogawa N., Satoh K., Kawagishi N., Sekiguchi S., Nilsson B., Okada N., Okada H., Satomi S., Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation. Transplantation 2010 90 12 1358 1365 2-s2.0-78650806319 10.1097/TP. 0b013e3181ffb9f5
62. Goto M., Tjernberg J., Dufrane D., Elgue G., Brandhorst D., Ekdahl K. N., Brandhorst H., Wennberg L., Kurokawa Y., Satomi S., Lambris J. D., Gianello P., Korsgren O., Nilsson B., Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 2008 15 4 225 234 2-s2.0-50949096307 10.1111/j.1399-3089.2008.00482.x
63. Luan N. M., Teramura Y., Iwata H., Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials 2010 31 34 8847 8853 2-s2.0-77957303282 10.1016/j.biomaterials.2010.08.004
64. Nagata M., Mullen Y., Matsuo S., Herrera M., Clare-Salzler M., Destruction of islet isografts by severe nonspecific inflammation. Transplantation Proceedings 1990 22 2 855 856 2-s2.0-0025305705 (Pubitemid 20160606)
65. Alejandro R., Cutfield R. G., Shienvold F. L., Polonsky K. S., Noel J., Olson L., Dillberger J., Miller J., Mintz D. H., Natural history of intrahepatic canine islet cell autografts. The Journal of Clinical Investigation 1986 78 5 1339 1348 2-s2.0-0023037573 (Pubitemid 17181574)
66. Nathan C. F., Secretory products of macrophages. The Journal of Clinical Investigation 1987 79 2 319 326 2-s2.0-0023147156 (Pubitemid 17009661)
67. Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M., Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986 232 4757 1545 1547 2-s2.0-0022445268 (Pubitemid 16061563)
68. Xenos E. S., Stevens R. B., Sutherland D. E., Lokeh A., Ansite J. D., Casanova D., Gores P. F., Platt J. L., The role of nitric oxide in IL-1 β -mediated dysfunction of rodent islets of Langerhans: implications for the function of intrahepatic islet grafts. Transplantation 1994 57 8 1208 1212 2-s2.0-0028271718 (Pubitemid 24139643)
69. Montgomery K. F., Osborn L., Hession C., Tizard R., Goff D., Vassallo C., Tarr P. I., Bomsztyk K., Lobb R., Harlan J. M., Pohlman T. H., Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proceedings of the National Academy of Sciences of the United States of America 1991 88 15 6523 6527 2-s2.0-0025948216 10.1073/pnas.88.15.6523 (Pubitemid 21914979)
70. Grilli M., Chiu J. J., Lenardo M. J., NF- κ B and Rel: participants in a multiform transcriptional regulatory system. International Review of Cytology 1993 143 1 62 2-s2.0-0027232067 (Pubitemid 23166972)
71. Degitz K., Li L.-J., Caughman S. W., Cloning and characterization of the 5′-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene. The Journal of Biological Chemistry 1991 266 21 14024 14030 2-s2.0-0025911970 (Pubitemid 21907456)
72. Wachlin G., Augstein P., Schröder D., IL-1 β IFN- γ and TNF- α increase vulnerability of pancreatic beta cells to autoimmune destruction. Journal of Autoimmunity 2003 20 4 303 312 2-s2.0-0037603320 10.1016/S0896-8411(03)00039-8 (Pubitemid 36677522)
73. Tan J., Zhou G., Chemokine receptors and transplantation. Cellular & Molecular Immunology 2005 2 5 343 349 2-s2.0-33645518668
74. Baker M. S., Chen X., Rotramel A. R., Nelson J. J., Lu B., Gerard C., Kanwar Y., Kaufman D. B., Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery 2003 134 2 126 133 2-s2.0-0041326683 10.1067/msy.2003.213 (Pubitemid 37070329)
75. Melzi R., Mercalli A., Sordi V., Cantarelli E., Nano R., Maffi P., Sitia G., Guidotti L. G., Secchi A., Bonifacio E., Piemonti L., Role of CCL2/MCP-1 in islet transplantation. Cell Transplantation 2010 19 8 1031 1046 2-s2.0-78349245540 10.3727/096368910X514639
76. Citro A., Cantarelli E., Maffi P., CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. The Journal of Clinical Investigation 2012 122 10 3647 3651 10.1172/JCI63089
77. Naziruddin B., Wease S., Stablein D., HLA class I sensitization in islet transplant recipients: report from the collaborative islet transplant registry. Cell Transplantation 2012 21 5 901 908 10.3727/096368911X612468
78. Roep B. O., Stobbe I., Duinkerken G., Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999 48 3 484 490 2-s2.0-0032971910 (Pubitemid 29106860)
79. van Kampen C. A., van de Linde P., Duinkerken G., van Schip J. J., Roelen D. L., Keymeulen B., Pipeleers D. G., Claas F. H. J., Roep B. O., Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. Transplantation 2005 80 1 118 126 2-s2.0-22144445286 10.1097/01.TP.0000164143.22287.E3 (Pubitemid 40980904)
80. Pujol-Borrell R., Todd I., Doshi M., HLA class II induction in human islet cells by interferon- γ plus tumour necrosis factor or lymphotoxin. Nature 1987 326 6110 304 306 2-s2.0-0023105107 (Pubitemid 17053756)
81. Soldevila G., Buscema M., Doshi M., James R. F. L., Bottazzo G. F., Pujol-Borrell R., Cytotoxic effect of IFN- γ plus TNF- α on human islet cells. Journal of Autoimmunity 1991 4 2 291 306 2-s2.0-0025759890 10.1016/0896-8411(91)90025-8
82. Jackson A. M., Connolly J. E., Matsumoto S., Noguchi H., Onaca N., Levy M. F., Naziruddin B., Evidence for induced expression of HLA class II on human islets: possible mechanism for HLA sensitization in transplant recipients. Transplantation 2009 87 4 500 506 2-s2.0-65649141959 10.1097/TP.0b013e318195fc33
83. Hearse D. J., Manning A. S., Downey J. M., Yellon D. M., Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiologica Scandinavica 1986 126 548 65 78 2-s2.0-0022527933 (Pubitemid 16090299)
84. Southorn P. A., Powis G., Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clinic Proceedings 1988 63 4 381 389 2-s2.0-0023925294
85. Zikria B. A., Mehmet O., Carlson R. W., Reperfusion Injuries and Clinical Capillary Leak Syndrome 1994 New York, NY, USA Futura
86. Malaisse W. J., Malaisse-Lagae F., Sener A., Pipeleers D. G., Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proceedings of the National Academy of Sciences of the United States of America 1982 79 3 927 930 2-s2.0-0038068896 (Pubitemid 12160335)
87. Lenzen S., Drinkgern J., Tiedge M., Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology & Medicine 1996 20 3 463 466 2-s2.0-0029984682 10.1016/0891-5849(96)02051-5 (Pubitemid 26077870)
88. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., Miyazaki J.-I., Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. The Journal of Experimental Medicine 1998 188 8 1445 1451 2-s2.0-0032547768 10.1084/jem.188.8.1445 (Pubitemid 28489581)
89. Hohmeier H.-E., Thigpen A., Tran V. V., Davis R., Newgard C. B., Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1 β -induced cytotoxicity and reduces nitric oxide production. The Journal of Clinical Investigation 1998 101 9 1811 1820 2-s2.0-0032080663 (Pubitemid 28226098)
90. Benhamou P. Y., Moriscot C., Richard M. J., Beatrix O., Badet L., Pattou F., Kerr-Conte J., Chroboczek J., Lemarchand P., Halimi S., Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 1998 41 9 1093 1100 2-s2.0-15644375700 10.1007/s001250051035 (Pubitemid 28394416)
91. Carlsson P.-O., Palm F., Andersson A., Liss P., Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001 50 3 489 495 2-s2.0-0035120134 (Pubitemid 32195212)
92. Arteel G. E., Thurman R. G., Yates J. M., Raleigh J. A., Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. British Journal of Cancer 1995 72 4 889 895 2-s2.0-0028785458
93. Carlsson P.-O., Liss P., Andersson A., Jansson L., Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998 47 7 1027 1032 2-s2.0-0031780344 10.2337/diabetes.47.7.1027 (Pubitemid 28294543)
94. Cantarelli E., Melzi R., Mercalli A., Sordi V., Ferrari G., Lederer C. W., Mrak E., Rubinacci A., Ponzoni M., Sitia G., Guidotti L. G., Bonifacio E., Piemonti L., Bone marrow as an alternative site for islet transplantation. Blood 2009 114 20 4566 4574 2-s2.0-73349109136 10.1182/blood-2009-03-209973
95. Maffi P., Balzano G., Ponzoni M., Autologous pancreatic islet transplantation in human bone marrow. Diabetes 2013 62 10 3523 3531 10.2337/db13-0465
96. Barshes N. R., Wyllie S., Goss J. A., Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. Journal of Leukocyte Biology 2005 77 5 587 597 2-s2.0-18244364592 10.1189/jlb.1104649 (Pubitemid 40628740)
97. Bottino R., Fernandez L. A., Ricordi C., Lehmann R., Tsan M.-F., Oliver R., Inverardi L., Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998 47 3 316 323 2-s2.0-0031890972 10.2337/diabetes.47.3. 316 (Pubitemid 28104190)
98. Vargas F., Vives-Pi M., Somoza N., Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 1998 65 5 722 727 2-s2.0-0032520793 10.1097/00007890-199803150-00020 (Pubitemid 28128945)
99. Gray D. W., Sutton R., McShane P., Peters M., Morris P. J., Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule. Journal of Surgical Research 1988 45 5 432 442 2-s2.0-0023692456 (Pubitemid 18260084)
100. Coffey L. C., Berman D. M., Willman M. A., Kenyon N. S., Immune cell populations in nonhuman primate islets. Cell Transplantation 2009 18 10-11 1213 1222 2-s2.0-75149181039 10.3727/096368909X12483162196728
101. Kanak M., Takita M., Itoh T., Alleviation of instant blood mediated inflammatory reaction in autologous conditions through treatment of human islets with NF- κ B inhibitors. Transplantation. In press
102. Lawrence M. C., Naziruddin B., Levy M. F., Jackson A., McGlynn K., Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF- α gene expression in pancreatic islet endocrine cells. The Journal of Biological Chemistry 2011 286 2 1025 1036 2-s2.0-78651383854 10.1074/jbc.M110.158675
103. Corbett J. A., McDaniel M. L., Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. The Journal of Experimental Medicine 1995 181 2 559 568 2-s2.0-0028900805 10.1084/jem.181.2.559
104. Cardozo A. K., Kruhøffer M., Leeman R., Ørntoft T., Eizirik D. L., Identification of novel cytokine-induced genes in pancreatic β -cells by high-density oligonucleotide arrays. Diabetes 2001 50 5 909 920 2-s2.0-0035029867 (Pubitemid 32374519)
105. Paraskevas S., Aikin R., Maysinger D., Lakey J. R. T., Cavanagh T. J., Agapitos D., Wang R., Rosenberg L., Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: insulin as an autocrine survival signal. Annals of Surgery 2001 233 1 124 133 2-s2.0-0035164537 10.1097/00000658-200101000-00018 (Pubitemid 32042782)
106. Abdelli S., Ansite J., Roduit R., Borsello T., Matsumoto I., Sawada T., Allaman-Pillet N., Henry H., Beckmann J. S., Hering B. J., Bonny C., Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 2004 53 11 2815 2823 2-s2.0-7044249537 10.2337/diabetes.53.11.2815 (Pubitemid 39425906)
107. Arnette D., Gibson T. B., Lawrence M. C., January B., Khoo S., McGlynn K., Vanderbilt C. A., Cobb M. H., Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic β cells. The Journal of Biological Chemistry 2003 278 35 32517 32525 2-s2.0-0041375468 10.1074/jbc.M301174200 (Pubitemid 37055689)
108. Lawrence M. C., McGlynn K., Park B.-H., Cobb M. H., ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. The Journal of Biological Chemistry 2005 280 29 26751 26759 2-s2.0-22844446279 10.1074/jbc.M503158200 (Pubitemid 41040708)
109. Lawrence M. C., McGlynn K., Shao C., Duan L., Naziruddin B., Levy M. F., Cobb M. H., Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in β -cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13315 13320 2-s2.0-51649088697 10.1073/pnas.0806465105
110. Fei H., Zhao B., Zhao S., Wang Q., Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1 β -induced β -cell apoptosis. Molecular and Cellular Biochemistry 2008 315 1-2 75 84 2-s2.0-46749142851 10.1007/s11010-008-9791-8
111. Paraskevas S., Aikin R., Maysinger D., Lakey J. R. T., Cavanagh T. J., Hering B., Wang R., Rosenberg L., Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: implications for cultured islet survival. FEBS Letters 1999 455 3 203 208 2-s2.0-0032815458 10.1016/S0014- 5793(99)00882-0 (Pubitemid 29333036)
112. Widenmaier S. B., Ao Z., Kim S.-J., Warnock G., McIntosh C. H., Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the β -cell pro-survival effects of glucose-dependent insulinotropic polypeptide. The Journal of Biological Chemistry 2009 284 44 30372 30382 2-s2.0-71049146229 10.1074/jbc.M109.060178
113. Omori K., Valiente L., Orr C., Rawson J., Ferreri K., Todorov I., Al-Abdullah I. H., Medicherla S., Potter A. A., Schreiner G. F., Kandeel F., Mullen Y., Improvement of human islet cryopreservation by a p38 MAPK inhibitor. American Journal of Transplantation 2007 7 5 1224 1232 2-s2.0-34247393334 10.1111/j.1600-6143.2007.01741.x (Pubitemid 46643096)
114. Matsuda T., Omori K., Vuong T., Pascual M., Valiente L., Ferreri K., Todorov I., Kuroda Y., Smith C. V., Kandeel F., Mullen Y., Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. American Journal of Transplantation 2005 5 3 484 493 2-s2.0-20044390358 10.1046/j.1600-6143.2004.00716.x (Pubitemid 40313339)
115. Noguchi H., Nakai Y., Ueda M., Masui Y., Futaki S., Kobayashi N., Hayashi S., Matsumoto S., Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia 2007 50 3 612 619 2-s2.0-33846821387 10.1007/s00125-006-0563-2 (Pubitemid 46215505)
116. SoRelle J. A., Itoh T., Peng H., Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia 2013 56 4 814 824 10.1007/s00125-012-2813-9
117. Spinas G. A., Palmer J. P., Mandrup-Poulsen T., Andersen H., Nielsen J. H., Nerup J., The bimodal effect of interleukin 1 on rat pancreatic beta-cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinologica 1988 119 2 307 311 2-s2.0-0023682778
118. Lawrence M. C., Shao C., McGlynn K., Naziruddin B., Levy M. F., Cobb M. H., Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription. Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22181 22186 2-s2.0-76049126005 10.1073/pnas.0912596106
119. Corbett J. A., Sweetland M. A., Wang J. L., Lancaster J. R. Jr., McDaniel M. L., Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proceedings of the National Academy of Sciences of the United States of America 1993 90 5 1731 1735 2-s2.0-0027534895 (Pubitemid 23069930)
120. Shao C., Lawrence M. C., Cobb M. H., Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 β in pancreatic β cells. The Journal of Biological Chemistry 2010 285 26 19710 19719 2-s2.0-77953734994 10.1074/jbc.M109.087486
121. Oetjen E., Blume R., Cierny I., Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1 β and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia 2007 50 8 1678 1687 2-s2.0-34447128957 10.1007/s00125-007-0712-2 (Pubitemid 47036657)
122. Sekine N., Ishikawa T., Okazaki T., Hayashi M., Wollheim C. B., Fujita T., Synergistic activation of NF- κ b and inducible isoform of nitric oxide synthase induction by interferon- γ and tumor necrosis factor- α in INS-1 cells. Journal of Cellular Physiology 2000 184 1 46 57 (Pubitemid 30349627)
123. Chang I., Kim S., Kim J. Y., Cho N., Kim Y.-H., Kim H. S., Lee M.-K., Kim K.-W., Lee M.-S., Nuclear factor κ B protects pancreatic β -cells from tumor necrosis factor- α -mediated apoptosis. Diabetes 2003 52 5 1169 1175 2-s2.0-0038142707 10.2337/diabetes.52.5.1169 (Pubitemid 36523352)
124. Heit J. J., Apelqvist Å. A., Gu X., Winslow M. M., Neilson J. R., Crabtree G. R., Kim S. K., Calcineurin/NFAT signalling regulates pancreatic β -cell growth and function. Nature 2006 443 7109 345 349 2-s2.0-33748929299 10.1038/nature05097 (Pubitemid 44435154)
125. Goodyer W. R., Gu X., Liu Y., Bottino R., Crabtree G. R., Kim S. K., Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Developmental Cell 2012 23 1 21 34 10.1016/j.devcel.2012.05. 014
126. Kim S., Millet I., Hun S. K., Ja Y. K., Myoung S. H., Lee M.-K., Kim K.-W., Sherwin R. S., Karin M., Lee M.-S., NF- κ B prevents β cell death and autoimmune diabetes in NOD mice. Proceedings of the National Academy of Sciences of the United States of America 2007 104 6 1913 1918 2-s2.0-33846928411 10.1073/pnas.0610690104 (Pubitemid 46239878)
127. Shapiro A. M. J., State of the art of clinical islet transplantation and novel protocols of immunosuppression. Current Diabetes Reports 2011 11 5 345 354 2-s2.0-80755189324 10.1007/s11892-011-0217-8
128. McCall M., Shapiro A. M. J., Update on islet transplantation. Cold Spring Harbor Perspectives in Medicine 2012 2 7 a007823 10.1101/cshperspect.a007823
129. Barton F. B., Rickels M. R., Alejandro R., Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012 35 7 1436 1445 10.2337/dc12-0063
130. Hering B. J., Kandaswamy R., Ansite J. D., Eckman P. M., Nakano M., Sawada T., Matsumoto I., Ihm S.-H., Zhang H.-J., Parkey J., Hunter D. W., Sutherland D. E. R., Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. The Journal of the American Medical Association 2005 293 7 830 835 2-s2.0-13844265752 10.1001/jama.293.7.830 (Pubitemid 40250366)
131. Froud T., Ricordi C., Baidal D. A., Hafiz M. M., Ponte G., Cure P., Pileggi A., Poggioli R., Ichii H., Khan A., Ferreira J. V., Pugliese A., Esquenazi V. V., Kenyon N. S., Alejandro R., Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. American Journal of Transplantation 2005 5 8 2037 2046 2-s2.0-22844450663 10.1111/j.1600-6143.2005.00957.x (Pubitemid 41039883)
132. Bellin M. D., Barton F. B., Heitman A., Harmon J., Balamurugan A. N., Kandaswamy R., Sutherland D. E., Alejandro R., Hering B. J., Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. American Journal of Transplantation 2012 12 6 1576 1583 2-s2.0-84859639864 10.1111/j.1600-6143.2011.03977.x
133. Kandaswamy R., Stock P. G., Skeans M. A., OPTN/SRTR, 2011 annual data report: pancreas. American Journal of Transplantation 2013 13, supplement s1 47 72 10.1111/ajt.12020
134. McCall M., Pawlick R., Kin T., Shapiro A. M. J., Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. American Journal of Transplantation 2012 12 2 322 329 2-s2.0-84856473153 10.1111/j.1600-6143.2011.03796.x
135. Matsumoto S., Takita M., Chaussabel D., Noguchi H., Shimoda M., Sugimoto K., Itoh T., Chujo D., Sorelle J., Onaca N., Naziruddin B., Levy M. F., Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1 β and TNF- α Cell Transplantation 2011 20 10 1641 1647 2-s2.0-79957525661
136. Matsuoka N., Itoh T., Watarai H., Sekine-Kondo E., Nagata N., Okamoto K., Mera T., Yamamoto H., Yamada S., Maruyama I., Taniguchi M., Yasunami Y., High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. The Journal of Clinical Investigation 2010 120 3 735 743 2-s2.0-77949756774 10.1172/JCI41360
137. Itoh T., Takita M., SoRelle J. A., Correlation of released HMGB1 levels with the degree of islet damage in mice and humans and with the outcomes of islet transplantation in mice. Cell Transplantation 2012 21 7 1371 1381 10.3727/096368912X640592
138. Itoh T., Iwahashi S., Kanak M. A., Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes. Cell Transplantation 2014 23 2 153 156 10.3727/096368912X658980
139. Pileggi A., Molano R. D., Berney T., Cattan P., Vizzardelli C., Oliver R., Fraker C., Ricordi C., Pastori R. L., Bach F. H., Inverardi L., Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001 50 9 1983 1991 2-s2.0-0035458338 (Pubitemid 33643664)
140. Poss K. D., Tonegawa S., Reduced stress defense in heme oxygenase 1-deficient cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10925 10930 2-s2.0-0030886054 10.1073/pnas.94.20. 10925 (Pubitemid 27430837)
141. Poss K. D., Tonegawa S., Heme oxygenase 1 is required for mammalian iron reutilization. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10919 10924 2-s2.0-0030886381 10.1073/pnas.94.20. 10919 (Pubitemid 27430836)
142. Günther L., Berberat P. O., Haga M., Brouard S., Neal Smith R., Soares M. P., Bach F. H., Tobiasch E., Carbon monoxide protects pancreatic β -cells from apoptosis and improves islet function/survival after transplantation. Diabetes 2002 51 4 994 999 2-s2.0-0036226971 (Pubitemid 34438341)
143. Grey S. T., Longo C., Shukri T., Patel V. I., Csizmadia E., Daniel S., Arvelo M. B., Tchipashvili V., Ferran C., Genetic engineering of a suboptimal islet graft with A20 preserves β cell mass and function. The Journal of Immunology 2003 170 12 6250 6256 2-s2.0-0037942826 (Pubitemid 36682610)
144. Cheng E. Y., Sharma V. K., Chang C., Ding R., Allison A. C., Leeser D. B., Suthanthiran M., Yang H., Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β -cell apoptosis, and improves early graft function. Transplantation 2010 90 7 709 716 2-s2.0-77957990554 10.1097/TP.0b013e3181ed55d8
145. Jin S.-M., Kim K. S., Lee S.-Y., Gong C.-H., Park S. K., Shin J. S., Park C.-G., Kim S.-J., The sequential combination of a JNK inhibitor and simvastatin protects porcine islets from peritransplant apoptosis and inflammation. Cell Transplantation 2011 20 7 1139 1151 2-s2.0-80053161046 10.3727/096368910X550170
146. Cure P., Pileggi A., Froud T., Messinger S., Faradji R. N., Baidal D. A., Cardani R., Curry A., Poggioli R., Pugliese A., Betancourt A., Esquenazi V., Ciancio G., Selvaggi G., Burke G. W. III, Ricordi C., Alejandro R., Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 2008 85 6 801 812 2-s2.0-41149101209 10.1097/TP.0b013e318166a27b (Pubitemid 351440744)
147. Froud T., Baidal D. A., Faradji R., Cure P., Mineo D., Selvaggi G., Kenyon N. S., Ricordi C., Alejandro R., Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. Transplantation 2008 86 12 1695 1701 2-s2.0-58849101815 10.1097/TP.0b013e31819025e5
148. Bellin M. D., Kandaswamy R., Parkey J., Zhang H.-J., Liu B., Ihm S. H., Ansite J. D., Witson J., Bansal-Pakala P., Balamurugan A. N., Papas K., Sutherland D. E. R., Moran A., Hering B. J., Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. American Journal of Transplantation 2008 8 11 2463 2470 2-s2.0-53749089122 10.1111/j.1600-6143. 2008.02404.x
149. Gangemi A., Salehi P., Hatipoglu B., Martellotto J., Barbaro B., Kuechle J. B., Qi M., Wang Y., Pallan P., Owens C., Bui J., West D., Kaplan B., Benedetti E., Oberholzer J., Islet transplantation for brittle type 1 diabetes: the UIC protocol. American Journal of Transplantation 2008 8 6 1250 1261 2-s2.0-44449092051 10.1111/j.1600-6143.2008.02234.x (Pubitemid 351763686) Kidney Diseases